Next Generation, Modifiable Cardiometabolic Biomarkers: Mitochondrial Adaptation and Metabolic Resilience
The Promise of Omics for Detecting and Treating Cardiometabolic Risk
Top Things to Know Next Generation Cardiometabolic Biomarkers Early Mechanistic and Modifiable
Heart Disease and Stroke Statistics—2023 Update
Nutrigenomics, the Microbiome, and Gene-Environment Interactions: New Directions in Cardiovascular Disease Research, Prevention, and Treatment
Nontraditional Risk Factors and Biomarkers for Cardiovascular Disease: Mechanistic, Research, and Clinical Considerations for Youth
Role of Biomarkers for the Prevention, Assessment, and Management of Heart Failure
